Literature DB >> 30539656

Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Rabi Yacoub1, Girish N Nadkarni2, Daniel I McSkimming3, Lee D Chaves1, Sham Abyad1, Mark A Bryniarski4, Amanda M Honan1, Shruthi A Thomas1, Madan Gowda1, John C He2, Jaime Uribarri2.   

Abstract

IMPACT STATEMENT: The heterogeneity of the renal disease, therapeutic interventions, and the original cause of the renal failure, all directly affect the microbiota. We delineate in this report the direct effect of decreased renal function on the bacterial composition following stringent criteria to eliminate the possibilities of other confounding factors and dissect the direct effects of the uremic milieu. We analyzed the microbiome following three different approaches to further evaluate the effects of mild, moderate and advanced renal insufficiency on the microbiome. We also present here a detailed functional analysis of the projected altered pathways secondary to changes in the microbiome composition.

Entities:  

Keywords:  PICRUSt analysis; Polycystic kidney disease; gut bacterial microbiota; hemodialysis; renal insufficiency; uremic milieu

Mesh:

Year:  2018        PMID: 30539656      PMCID: PMC6547006          DOI: 10.1177/1535370218818175

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  74 in total

1.  Small bowel motility and colonic transit are altered in dogs with moderate renal failure.

Authors:  H P Lefebvre; J P Ferré; A D Watson; C A Brown; J P Serthelon; V Laroute; D Concordet; P L Toutain
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-07       Impact factor: 3.619

Review 2.  Risks of chronic metabolic acidosis in patients with chronic kidney disease.

Authors:  Joel D Kopple; Kamyar Kalantar-Zadeh; Rajnish Mehrotra
Journal:  Kidney Int Suppl       Date:  2005-06       Impact factor: 10.545

3.  Resistance to growth hormone and insulin-like growth factor-I in acidotic rats.

Authors:  F A Ordóñez; F Santos; V Martínez; E García; P Fernández; J Rodríguez; M Fernández; J Alvarez; S Ferrando
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

4.  Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.

Authors:  Tsuneo Deguchi; Sumio Ohtsuki; Masaki Otagiri; Hitomi Takanaga; Hiroshi Asaba; Shinobu Mori; Tetsuya Terasaki
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

Review 5.  Serum gastrin concentration in chronic renal failure.

Authors:  P Kes
Journal:  Acta Med Croatica       Date:  1992

6.  Colonic transit time in long-term dialysis patients.

Authors:  Ming-Ju Wu; Chi-Sen Chang; Chi-Hung Cheng; Cheng-Hsu Chen; Wen-Chin Lee; Yu-Huang Hsu; Kuo-Hsiung Shu; Ming-Jer Tang
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

7.  Evidence for impaired assimilation of protein in chronic renal failure.

Authors:  Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

8.  Uremia increases gastric mucosal permeability and acid back-diffusion injury in the rat.

Authors:  E Quintero; J Kaunitz; Y Nishizaki; R De Giorgio; C Sternini; P H Guth
Journal:  Gastroenterology       Date:  1992-12       Impact factor: 22.682

9.  Development of a symptom assessment instrument for chronic hemodialysis patients: the Dialysis Symptom Index.

Authors:  Steven D Weisbord; Linda F Fried; Robert M Arnold; Armando J Rotondi; Michael J Fine; David J Levenson; Galen E Switzer
Journal:  J Pain Symptom Manage       Date:  2004-03       Impact factor: 3.612

10.  Acidosis impairs insulin receptor substrate-1-associated phosphoinositide 3-kinase signaling in muscle cells: consequences on proteolysis.

Authors:  Harold A Franch; Sina Raissi; Xiaonan Wang; Bin Zheng; James L Bailey; S Russ Price
Journal:  Am J Physiol Renal Physiol       Date:  2004-05-25
View more
  5 in total

1.  Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.

Authors:  Katharina Hopp; Emily K Kleczko; Berenice Y Gitomer; Michel Chonchol; Jost Klawitter; Uwe Christians; Jelena Klawitter
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17

2.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

3.  Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease.

Authors:  Ashani Lecamwasam; Tiffanie M Nelson; Leni Rivera; Elif I Ekinci; Richard Saffery; Karen M Dwyer
Journal:  Biomedicines       Date:  2020-12-29

Review 4.  Insights Into the Molecular Mechanisms of Polycystic Kidney Diseases.

Authors:  Valeriia Y Vasileva; Regina F Sultanova; Anastasia V Sudarikova; Daria V Ilatovskaya
Journal:  Front Physiol       Date:  2021-09-08       Impact factor: 4.566

Review 5.  Gut Dysbiosis and Kidney Diseases.

Authors:  Chujin Cao; Han Zhu; Ying Yao; Rui Zeng
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.